Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pd, Lundin"'
Publikováno v:
Europe PubMed Central
The intestinal absorption enhancement of the nonapeptide [Mpa1,D-Arg8]vasopressin (dDAVP) by medium-chain glyceride vehicles was studied using an in vivo rat model. Rats were gavaged with dDAVP formulated with three different lipid vehicles: (1) mono
Autor:
Lundin PD; Experimental Medicine, Astra-Zeneca R & D Mölndal, S-431 83 Mölndal, Sweden. pal.lundin@astrazeneca.com, Edsbäcker S, Bergstrand M, Ejderhamn J, Linander H, Högberg L, Persson T, Escher JC, Lindquist B
Publikováno v:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2003 Jan; Vol. 17 (1), pp. 85-92.
Autor:
Taljanski W; Department of Immunology, National Research Institute of Mother and Child, Warsaw, Poland. insmatki@warman.com.pl, Pierzynowski SG, Lundin PD, Westrom BR, Eirefelt S, Podlesny J, Dahlback M, Siwinska-Golebiowska H, Karlsson BW
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 1997 Aug; Vol. 25 (8), pp. 917-20.
Autor:
Lundin PD; Department of Animal Physiology, Lund University, Sweden. Pal.Lundin@zoofys.lu.se, Bojrup M, Ljusberg-Wahren H, Weström BR, Lundin S
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 1997 Aug; Vol. 282 (2), pp. 585-90.
Autor:
Lundin PD; Dept. of Animal Physiology, Lund University, Sweden., Ekström G, Erlansson M, Lundin S, Weström BR
Publikováno v:
Scandinavian journal of gastroenterology [Scand J Gastroenterol] 1997 Jul; Vol. 32 (7), pp. 700-5.
Autor:
Lundin PD; Department of Animal Physiology, University of Lund, Sweden., Weström BR, Pantzar N, Karlsson BW
Publikováno v:
Digestive diseases and sciences [Dig Dis Sci] 1997 Mar; Vol. 42 (3), pp. 677-83.